Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $964.08 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $323.69 | 11 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $138.75 | 8 | $0 (2022) |
| ABBVIE INC. | $102.66 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $94.12 | 5 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $67.56 | 5 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $59.81 | 2 | $0 (2022) |
| Alkermes, Inc. | $42.26 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $41.84 | 3 | $0 (2022) |
| Lundbeck LLC | $29.81 | 2 | $0 (2023) |
| Corium, LLC | $20.82 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.88 | 1 | Otsuka America Pharmaceutical, Inc. ($121.88) |
| 2023 | $91.49 | 5 | ABBVIE INC. ($52.11) |
| 2022 | $423.75 | 23 | Supernus Pharmaceuticals, Inc. ($138.75) |
| 2021 | $326.96 | 19 | Otsuka America Pharmaceutical, Inc. ($120.10) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/30/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/19/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/13/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $7.48 | General |
| Category: PSYCHOLOGY | ||||||
| 07/12/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.70 | General |
| Category: PSYCHOLOGY | ||||||
| 06/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.99 | General |
| Category: PSYCHOLOGY | ||||||
| 05/03/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: PSYCHOLOGY | ||||||
| 04/20/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $20.50 | General |
| Category: PSYCHOLOGY | ||||||
| 04/05/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: PSYCHOLOGY | ||||||
| 03/24/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PSYCHIATRY | ||||||
| 03/23/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Neuroscience | ||||||
| 03/01/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: PSYCHIATRY | ||||||
| 02/24/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: PSYCHOLOGY | ||||||
| 02/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Central Nervous System | ||||||
| 02/16/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
About Alexis Ali
Alexis Ali is a Psychiatric/Mental Health healthcare provider based in Tigard, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2021. The National Provider Identifier (NPI) number assigned to this provider is 1841883501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexis Ali has received a total of $964.08 in payments from pharmaceutical and medical device companies, with $121.88 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($964.08).
Practice Information
- Specialty Psychiatric/Mental Health
- Location Tigard, OR
- Active Since 02/14/2021
- Last Updated 02/14/2021
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1841883501
Products in Payments
- REXULTI (Drug) $194.17
- QELBREE (Drug) $138.75
- VRAYLAR (Drug) $102.66
- TRINTELLIX (Drug) $94.12
- ABILIFY MAINTENA (Drug) $89.52
- ABILIFY MYCITE (Drug) $69.81
- LATUDA (Drug) $67.56
- HETLIOZ (Drug) $59.81
- LYBALVI (Drug) $42.26
- AUSTEDO (Drug) $41.84
- Azstarys (Drug) $20.82
- JORNAY PM (Drug) $15.50
- SPRAVATO (Drug) $14.83
- NURTEC ODT (Drug) $12.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Tigard
Mr. Erik Morris, Np, NP
Psychiatric/Mental Health — Payments: $879.27
Timothy Perez, Rn, Mn, Pmhnp-Bc, RN, MN, PMHNP-BC
Psychiatric/Mental Health — Payments: $877.08
Mrs. Jennifer Nieves, Aprn, APRN
Psychiatric/Mental Health — Payments: $376.94
Ms. Mary Blankenship, Rn, Fnp, Pmhnp-Bc, RN, FNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $299.15
Mrs. Brittany Monson, Phmnp, PHMNP
Psychiatric/Mental Health — Payments: $148.42
Rachael Marges, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $134.38